EUVIMEDEUVIMED entdecken
Open Access

Stepwise Differentiation of Mouse Embryonic Stem Cells Into Murine Blood Vessel Organoids With Endothelial Lineage Tracing for Quality Control

Sophie Guelfi, Sarah Bopp, Gabriele Bergers

BIO-PROTOCOL · 2026 · 16 (1400)

DOI: 10.21769/bioprotoc.5727 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BIO-PROTOCOL, 2026. Verfasst von Sophie Guelfi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Tumor Microenvironment and Therapeutic Resistance, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In vitro vascular models are most informative when they recapitulate endothelial assembly within a 3D microenvironment. Blood vessel organoids (BVOs) enable the study of vascular heterogeneity, function, and organ-instructive cues in development, homeostasis, and disease. Here, we present a robust stepwise method to generate murine blood vessel organoids (mBVOs) from feeder-dependent mouse embryonic stem cells (mESCs) of common genetic backgrounds. Embryoid bodies (EBs) are formed using strain-specific seeding densities (day 0-3), followed by mesoderm induction (day 3-6) and vascular induction (day 6-8). Induced EBs are embedded in collagen I with Geltrex to drive sprouting and network formation (day 8-13). Vascular networks are microdissected and grown in suspension to yield mature mBVOs (day 21-30). The inclusion of a Cre-inducible VE-cadherin-GFP reporter line enables a quantitative quality control, reducing variability by excluding poorly differentiated organoids. The protocol reliably produces ~100 mBVOs per differentiation and is compatible with engineered mouse strains for gain- and loss-of-function studies, functional assays of vascular plasticity, and syngeneic grafting to assess perfusion. Thus, mBVOs provide a scalable and traceable 3D platform that bridges endothelial assays, mouse models, and human organoid systems. Key features • A detailed timeline to differentiate feeder-dependent mESCs into mBVOs, with key success readouts and troubleshooting. • Efficient across three genetic backgrounds with strain-specific EB seeding densities and typical yields of ~100 mBVOs per differentiation. • The inducible VE-cadherin-GFP lineage tracing/reporter system provides an endothelial quality control to quantify efficiency and exclude poorly differentiated organoids. • Compatible with engineered mouse strains for gain/loss-of-function, with in vitro assays of vascular plasticity/remodeling, and with syngeneic in vivo validation.

Schlagwörter

Stichwörter der Autor:innen

Embryoid bodies (EBs)Feeder-dependent cultureMouse embryonic stem cells (mESCs)Murine blood vessel organoids (mBVOs)Quality control of differentiationSprouting angiogenesisVE-cadherin (Cdh5) lineage tracingVascular differentiation

Autor:innen und Institutionen

  • Laboratory of Tumor Microenvironment and Therapeutic Resistance, VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.
  • Department of Oncology, KU Leuven, Leuven, Belgium.

Zitieren

APA

Guelfi, S., Bopp, S., & Bergers, G. (2026). Stepwise Differentiation of Mouse Embryonic Stem Cells Into Murine Blood Vessel Organoids With Endothelial Lineage Tracing for Quality Control. BIO-PROTOCOL, 16(1400). https://doi.org/10.21769/bioprotoc.5727

Vancouver

Guelfi S, Bopp S, Bergers G. Stepwise Differentiation of Mouse Embryonic Stem Cells Into Murine Blood Vessel Organoids With Endothelial Lineage Tracing for Quality Control. BIO-PROTOCOL. 2026;16(1400). doi:10.21769/bioprotoc.5727

BibTeX
@article{Guelfi2026,
  author = {Guelfi, Sophie and Bopp, Sarah and Bergers, Gabriele},
  title = {Stepwise Differentiation of Mouse Embryonic Stem Cells Into Murine Blood Vessel Organoids With Endothelial Lineage Tracing for Quality Control},
  journal = {BIO-PROTOCOL},
  year = {2026},
  volume = {16},
  number = {1400},
  doi = {10.21769/bioprotoc.5727}
}
Kostenlos starten →